Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight: Amgen
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes
2023 Oncology Guide to Patient Support Services
MOD_SEARCH_LABEL_TEXT
Rigel Pharmaceuticals
2023 Oncology Guide to Patient Support Services
Rigel Pharmaceuticals offers the
Rigel OneCare
patient support program to assist patients while taking Tavalisse.
Read More ›
Sandoz
2023 Oncology Guide to Patient Support Services
Sandoz, a Novartis Division, offers the
Sandoz One Source
patient support program to assist patients while taking Zarxio or Ziextenzo.
Read More ›
Sanofi
2023 Oncology Guide to Patient Support Services
Sanofi offers the
CareASSIST Program
to assist patients prescribed certain Sanofi medications.
Read More ›
Seagen
2023 Oncology Guide to Patient Support Services
Seagen offers the
Seagen Secure
patient assistance program to help patients while taking a Seagen oncology medication.
Read More ›
Secura Bio
2023 Oncology Guide to Patient Support Services
Secura Bio offers the
Secura Care Patient Support Program
to assist patients while taking Copiktra.
Read More ›
Servier
2023 Oncology Guide to Patient Support Services
The
ServierONE
patient support program provides patients with financial assistance and one-on-one support when prescribed a Servier oncology product.
Read More ›
Spectrum Pharmaceuticals
2023 Oncology Guide to Patient Support Services
Spectrum Pharmaceuticals offers the
Access4Me
program to provide access and reimbursement support to patients who have been prescribed Rolvedon.
Read More ›
Sun Pharma
2023 Oncology Guide to Patient Support Services
Sun Pharma offers the
Yonsa Support
program and the
Odomzo Support
program to help patients while taking these medications.
Read More ›
Swedish Orphan Biovitrum
2023 Oncology Guide to Patient Support Services
Sobi offers the
Doptelet Connect
program to provide access and reimbursement support to patients who have been prescribed Doptelet.
Read More ›
Taiho Oncology
2023 Oncology Guide to Patient Support Services
Taiho Oncology offers the
Taiho Oncology Patient Support
program to help patients while taking Inqovi, Lonsurf, or Lytgobi.
Read More ›
Takeda Oncology
2023 Oncology Guide to Patient Support Services
Takeda Oncology offers the
Here2Assist
support program to help patients who are prescribed a Takeda Oncology treatment.
Read More ›
TerSera Therapeutics
2023 Oncology Guide to Patient Support Services
TerSera Therapeutics offers the
TerSera SupportSource
program to help patients while taking a TerSera oncology medicine.
Read More ›
Teva Oncology
2023 Oncology Guide to Patient Support Services
Teva Oncology offers the
Comprehensive Oncology Reimbursement Expertise (CORE)
program and the
Teva Cares Foundation Patient Assistance Program
to help patients while taking a Teva Oncology treatment.
Read More ›
UroGen Pharma
2023 Oncology Guide to Patient Support Services
UroGen Pharma offers the
UroGen Support
program to assist patients while taking Jelmyto.
Read More ›
Viatris
2023 Oncology Guide to Patient Support Services
Viatris offers the
Viatris Advocate
program to provide continuous access and support to patients who have been prescribed Fulphila or Ogivri.
Read More ›
Page 4 of 4
1
2
3
4
View the Latest Issue of OPM
Read Issue
Top Trending Articles
1.
Molecular Characteristics Increasingly Define Adult Gliomas
By
William King
2.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
By
William King
3.
Optimal Systemic Therapy for Renal Cell Carcinoma Is Still Evolving
By
William King
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight: Amgen
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes